Bausch & Lomb CorpBLCO

時価総額

$53.3億

PER

眼科医療製品の大手。コンタクトレンズ、処方薬、手術器具を展開。23年6月のXIIDRA買収（17.5億ドル）と24年7月のTrukera買収（約2400万ドル）を実施。世界約100カ国で展開、製造拠点は23拠点10カ国。

	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net (loss) income	15	-248	-305
Depreciation and amortization of intangible assets	379	382	436
Amortization of Debt Issuance Costs and Discounts	8	30	20
Asset impairments	1	-	5
Allowances for losses on trade receivables and inventories	25	21	26
Deferred income taxes	-90	-10	-10
Gain on sale of assets	-	-	5
Share-based compensation	62	74	92
Foreign exchange gain (loss)	7	-12	-10
Gain excluded from hedge effectiveness	6	13	13
Amortization, Interim Contract And Inventory Step From Acquisition	-	23	82
Other	19	3	19
Trade receivables	95	121	227
Inventories	106	264	147
Prepaid expenses and other current assets	7	147	-161
Accounts payable, accrued and other liabilities	189	245	126
Net cash provided by (used in) operating activities	345	-17	232
Acquisitions and other investments	45	1,941	138
Purchases of property, plant and equipment	175	181	291
Purchases of marketable securities	17	17	12
Proceeds from sale of marketable securities	22	16	14
Proceeds from Divestiture of Businesses, Net of Cash Divested	-	1	2
Interest settlements from cross-currency swaps	-	13	13
Net cash used in investing activities	-215	-2,109	-412
Proceeds from Issuance of Long-Term Debt	2,440	2,276	631
Repayments of debt	13	161	430
Payment of employee withholding taxes related to share-based awards	-	10	12
Payments of financing costs	3	16	-
Payments of noncontrolling interest distributions	11	9	10
Net Borrowings, Financing Activities	31	-	-
Net transfers to BHC (Note 3)	2,363	-	-
Other	-	-2	-1
Net cash provided by financing activities	81	2,078	178
Effect of exchange rate changes on cash and cash equivalents and restricted cash	-8	2	-16
Net (decrease) increase in cash and cash equivalents and restricted cash	203	-46	-18
Capital Expenditures Incurred but Not yet Paid	-	65	56
Notes Issued	2,200	-	-